Cargando…
Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018
IMPORTANCE: The high and increasing expenditures for prescription medications in the US is a national problem. OBJECTIVE: To explore the association of generic statin competition on relevant use and cost savings and to provide use and expenditure trends for all available statins for private and publ...
Autores principales: | Lin, Shuo-yu, Baumann, Kyle, Zhou, Chenxuan, Zhou, Weiyu, Cuellar, Alison Evans, Xue, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609409/ https://www.ncbi.nlm.nih.gov/pubmed/34807258 http://dx.doi.org/10.1001/jamanetworkopen.2021.35371 |
Ejemplares similares
-
Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013) -
Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015) -
Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020) -
Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis
por: Sicras-Mainar, A., et al.
Publicado: (2018)